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Abstract
Introduction: Severe sepsis during pregnancy or in the postpartum period is a rare clinical event. In non obstetric
surviving patients, the cardiovascular changes seen in sepsis and septic shock are fully reversible five to ten days
after their onset. We report a case of septic myocardial dysfunction lasting longer than ten days. To the best of our
knowledge, this is the first report of prolonged septic myocardial dysfunction in a parturient.
Case presentation: A 24 year old Hispanic woman with no previous medical history developed pyelonephritis and
severe sepsis with prolonged myocardial dysfunction after a normal spontaneous vaginal delivery.
Conclusions: Septic myocardial dysfunction may be prolonged in parturients requiring longer term follow up and
pharmacologic treatment.
Introduction
Septic shock in obstetric patients is a rare clinical event.
The estimated incidence is one in 8,338 deliveries [1]. In
one case series of 18 obstetric patients that developed
septic shock, two thirds of patients were in the antepar-
tum period and one third, postpartum. The most com-
mon cause of septic shock was pyelonephritis, and the
most common pathogen isolated was Escherichia coli.
Myocardial dysfunction was common among these
patients. Another series included ten obstetric patients
with septic shock and five patients (50%) were found to
have evidence of left ventricular dysfunction [2]. All
patients had improvement in ventricular function during
their hospitalization. Neither of these series, however,
provided information on the duration of myocardial dys-
function in obstetric patients. In surviving non obstetric
patients, myocardial dysfunction has been shown to be
fully reversible in five to ten days after its onset [3]. We
present a case of a parturient with prolonged septic
myocardial dysfunction leading to symptomatic heart
failure.
Case presentation
A 24 year old nulliparous Hispanic woman with no past
medical history presented at 40 weeks of gestation in
active labor. Her antenatal course had been uncompli-
cated and her labor was uneventful.
12 hours after delivery, she complained of chills, dia-
phoresis, and right sided back pain. She had a fever of
40°C, a heart rate of 110 beats per minute, a blood pres-
sure of 136/85mmHg, and a respiratory rate of 20
breaths per minute. On examination, she had marked
right costovertebral tenderness. Laboratory tests showed
a white blood cell count of 18,000 white blood cells/μL
and urinalysis of 3+ blood, 3+ leukocyte esterase, and 49
white blood cells per high powered field. Our patient
was started on intravenous antibiotics for presumed
pyelonephritis.
36 hours after delivery, she complained of extreme dif-
ficulty breathing, non productive cough, and generalized
malaise. Her fever had risen to 40.5°C. Her heart rate
was 136 beats per minute, blood pressure of 136/
82mmHg, respiratory rate of 32 breaths per minute and
arterial oxygen saturation 76% on room air. A chest film
showed poor aeration in both lung bases and large bilat-
eral pleural effusions. Blood cultures and urine cultures
both grew E. coli.
40 hours after delivery, she was intubated. A 12 lead
electrocardiogram showed sinus tachycardia with no
ischemic changes. Troponins levels were not elevated
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and a transthoracic echocardiogram showed a depressed
ventricular ejection fraction of 35%. Both the right and
left ventricle appeared hypokinetic with normal end dia-
stolic diameters. Valvular function was normal. Chest
computed tomography (CT) with intravenous contrast
showed significant bilateral airway disease and no evi-
dence of a pulmonary embolus.
On postpartum day five, our patient was extubated. On
the eighth postpartum day, a cardiologist evaluated her
for continued complaints of shortness of breath, orthop-
nea, and poor exercise tolerance. Metoprolol and furose-
mide were started for systolic heart failure; however, she
continued to have persistent dyspnea and poor exercise
tolerance despite pharmacologic treatment. Ten days
postpartum she had a second transthoracic echocardio-
gram which showed a persistent decreased ejection frac-
tion of 35%. 11 days postpartum, she was discharged
home on oral antibiotics, furosemide, and metoprolol.
On postpartum day 21, our patient presented to the
Emergency Department with complaints of heavy vaginal
bleeding for which she received treatment with intrave-
nous crystalloid solution. During this visit, she reported
adherence with her medications, but continued dyspnea
and poor exercise tolerance. She could walk only one
block without developing shortness of breath and was
having considerable difficulty ascending three flights of
stairs. Her vital signs at that time were temperature of
36°C, respiratory rate of 16 breaths per minute, heart rate
of 57 beats per minute, and blood pressure of 120/
72mmHg. She had a normal blood hematocrit and did
not require blood transfusion. She was advised to con-
tinue her diuretic and beta blocker and discharged from
the emergency department with a plan to follow up as an
outpatient. Unfortunately, she did not return to our med-
ical center after this visit and we were unable to contact
her despite numerous attempts.
Discussion
Cardiovascular dysfunction is a defining feature of
severe sepsis and septic shock [4]. Typically, myocardial
dysfunction and decreased ventricular ejection fraction
occurs within the first 24 to 48 hours after the onset of
sepsis. In surviving non obstetric patients, these changes
have been shown to be fully reversible in five to ten
days.
The mechanisms of myocardial dysfunction during
sepsis are not fully understood, but have been elucidated
over the last several decades. One early hypothesis was
that coronary blood flow might be compromised during
sepsis leading to decreased myocardial performance.
However, it has been shown that coronary flow actually
increases during sepsis. Another hypothesis was that cir-
culating myocardial depressant substances are responsi-
ble for myocardial dysfunction during sepsis. This
hypothesis has been supported by evidence showing
serum from patients with sepsis can depress in vitro
contraction of animal muscle fibers [5]. Two of the cir-
culating myocardial depressant substances are thought
to be the cytokines, tumor necrosis factor and interleu-
kin 1B [6]. These molecules can cause myocardial
depression through a mechanism involving high levels
of intracellular cyclic guanosine monophosphate (GMP)
and nitric oxide [7]. Other mechanisms that have been
implicated in septic myocardial dysfunction include:
apoptosis, mitochondrial dysfunction, and abnormal
intracellular calcium homeostasis in cardiac myocytes.
Increased matrix metalloproteinase activity and auto-
nomic nervous system dysfunction have also been
described as possible etiologies [8]. During pregnancy
there are normal physiologic changes in the human car-
diovascular system. These include an increase in the
blood volume, an increase in heart rate, a decrease in
systemic vascular resistance, and an increase in cardiac
output. Left ventricular function is normal during preg-
nancy and ejection fraction is not significantly
decreased. In this case, myocardial dysfunction from
sepsis was prolonged in our obstetric patient leading to
systolic heart failure. The mechanism for this prolonged
myocardial dysfunction is not clear. However, previous
animal studies have shown that during the third trime-
ster of pregnancy there is an enhanced non specific
immunological reaction to endotoxin which leads to
higher levels of circulating cytokines such as tumor
necrosis factor alpha and interleukin-1. Both molecules
are myocardial depressant substances and could be
partly responsible for the prolongation of septic myocar-
dial dysfunction in parturients [9]. Other cellular
mechanisms of septic myocardial dysfunction may also
be potentiated by the enhanced immunological response
to sepsis during pregnancy, but this is speculative.
The differential diagnosis of heart failure in a parturi-
ent includes peripartum cardiomyopathy, myocarditis,
and other cardiomyopathies such as viral, familial,
dilated, hypertrophic, or drug related. In this case, our
patient did not meet the consensus definition for peri-
partum cardiomyopathy which requires that there be no
identifiable cause for cardiac failure other than preg-
nancy [10]. She also did not have a dilated left ventricle,
which is commonly found in peripartum cardiomyopa-
thy [11]. In another previously reported case, a parturi-
ent developed septic myocardial dysfunction leading to
heart failure, which mimicked a peripartum cardiomyo-
pathy [12]. In this case, the patient developed severe
sepsis from endometritis. Myocardial dysfunction was
profound with a decrease in ejection fraction to 28%.
The patient had symptoms of shortness of breath and
lower extremity edema. However, by postoperative day
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number 11, myocardial function had entirely returned to
normal and there were no long term sequelae.
It also seemed unlikely that our patient had pre exist-
ing cardiac disease which was exacerbated by severe sep-
sis because she reported previous good health before
and during her pregnancy. We did not believe myocar-
ditis was likely because of the normal troponin level and
electrocardiogram. An endomyocardial biopsy could
have been performed, but the rate of a positive biopsy is
low even in those with high suspicion for myocarditis
and the procedure is invasive [13].
The treatment of septic myocardial dysfunction involves
aggressive intravenous pre load resuscitation with either
crystalloid or colloid, the use of ionotropic and vasopres-
sor drugs for treating arterial hypotension, and possibly
the use of simvastatin which inhibits 3-hydroxy-methylglu-
taryl coenzyme A pathways [14]. Interestingly, our patient
was not hypotensive and treatment with ionotropes or
vasopressors was not required. She did initially require
crystalloid resuscitation in the intensive care unit. Septic
myocardial dysfunction in our patient manifested as symp-
toms of congestive heart failure and dyspnea on exertion.
For this reason, she was treated with both a beta blocker
and a diuretic because these are first line drug therapies
for systolic heart failure. Beta blockers typically increase
ejection fraction by five to ten percent in patients with sys-
tolic heart failure and improve symptoms [15]. Angioten-
sin converting enzyme inhibitors are also a first line drug
therapy for systolic heart failure but were not started in
our patient because of their possible teratogenic effects in
her developing infant [16].
A limitation of this report is that we did not measure
levels of myocardial depressant substances such as tumor
necrosis factor and interleukin 1B as measurement is not
standard in clinical practice. In addition, there is lack of
long term follow up with our patient. However, our
patient had confirmed persistent myocardial dysfunction
on a transthoracic echocardiogram on postpartum day
ten and symptoms of heart failure on postpartum day 21.
We believe these facts indicate that septic myocardial
dysfunction may be prolonged in parturients.
Conclusions
This case demonstrates that myocardial dysfunction
from severe sepsis may be prolonged in parturients
requiring longer term follow up and pharmacological
therapy for symptom relief.
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